Results 261 to 270 of about 1,859,821 (399)

MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice [PDF]

, 2013
Lisa Honeyman, Mark Bazett, Tomasz G. Tomko, Christina K. Haston   +3 more
openalex   +1 more source

Idiopathic pulmonary fibrosis: Disease mechanisms and drug development.

Pharmacology and Therapeutics, 2020
P. Spagnolo, J. Kropski, Mark G. Jones, Joyce S. Lee, G. Rossi, T. Karampitsakos, T. Maher, A. Tzouvelekis, C. Ryerson   +8 more
semanticscholar   +1 more source

Descriptive Epidemiology From the Myhre Syndrome Foundation Registry: The Value of Self‐Reported Data

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Myhre syndrome is an ultrarare genetic disease characterized by short stature, distinct craniofacial features, cardiovascular and respiratory fibrosis and stenosis, neurodevelopmental delays, autism, intellectual disability, and hearing loss. The natural history of Myhre syndrome is still not fully understood due to a small patient population ...
Mary K. Young, Armelle Pindon, Maggie R. Brand, Kate Wears, Katherine H. Young, Alyssa Mendel, Michael J. Lyons   +6 more
wiley   +1 more source

Chemical Synthesis of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii Capsular Polysaccharide Fragments as Leads for Cross‐Protection

Angewandte Chemie, EarlyView.
A total of 16 chemically synthesized capsular polysaccharide (CPS) fragments related to Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii were analyzed by glycan microarray. Comparative screening revealed three conserved epitopes that act as cross‐protective vaccine lead candidates against multidrug‐resistant (MDR) bacterial ...
Amar Kumar Mishra, Emelie E. Reuber, Diksha Rai, Leif E. Sander, Julia Duerr, Simon Y. Graeber, Marcus A. Mall, Bettina C. Fries, Peter H. Seeberger, Suvarn S. Kulkarni   +9 more
wiley   +2 more sources

Spontaneous pneumothorax in a dog with interstitial pulmonary fibrosis and ruptured bullae. [PDF]

J Vet Diagn Invest
Hille MM, Timmons MS, Loy DS.
europepmc   +1 more source

Health-related quality of life and health state utility value in idiopathic pulmonary fibrosis: a systematic review and meta-analysis [PDF]

Guixiang Zhao, Siyuan Lei, Ya Li, Zhenzhen Feng, Jiansheng Li   +4 more
openalex   +1 more source

Establishment of a biosafe murine model of skeletal tuberculosis using Mycobacterium smegmatis

Animal Models and Experimental Medicine, EarlyView.
This study developed a biosafe, accessible, and versatile murine model of bone TB using Mycobacterium smegmatis, a fast‐growing, nonpathogenic mycobacterial species with high genomic homology to Mycobacterium tuberculosis. Three infection routes—subperiosteal calvarial injection, intratibial injection, and intracardiac (left ventricular) inoculation ...
Yewei Jia, Yuhuai Guo, Yusheng Yang, Jie Zhang, Ziyang Zhang, Ying Qu, Jiulin Tan, Jie Shen, Nathachit Limjunyawong, Jianzhong Xu, Zehua Zhang, Fei Luo, Ce Dou   +12 more
wiley   +1 more source

Survival in familial idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Reis Estrella D, Mancuzo E, De Amorim Correa R, Tibana R, Soares MR, De Castro Pereira CA.   +5 more
europepmc   +1 more source

Animal models of benign airway stenosis: Advances in construction techniques, evaluation systems, and perspectives

Animal Models and Experimental Medicine, EarlyView.
Currently, the animals commonly used to establish animal models of benign airway stenosis (BAS) include mice, rats, pigs, dogs, rabbits, and ferrets. The establishment methods involve one or a combination of two methods such as mechanical injury, tracheal cautery, cuff overpressure intubation, laser injury, and endoscopic silver nitrate cauterization ...
Wusheng Zhang, Yilin Chen, Chengcheng Yang, Yuchao Dong, Haidong Huang, Hui Shi, Chong Bai   +6 more
wiley   +1 more source

Stem cell therapies for pulmonary fibrosis: emerging hope through ongoing challenges. [PDF]

Stem Cell Res Ther
Shi H, Geng R, Liu H.
europepmc   +1 more source